While not yet definitive predictors, such patterns warrant further investigation and may support future strategies incorporating hormonal surveillance, anatomical assessment, and timely pharmacologic adjuncts (e.g., GLP-1 receptor agonists) to optimize surgical outcomes
Ethics statement The studies involving humans were approved by Institutional Review Board at the University of Rome Tor Vergata (RS53.22)
Here are the key scenarios to remember: New and Expectant Parents: Newborns may be eligible for CHAMPVA
The article says weight loss can temporarily shift thyroid hormone metabolism, and that TSH and free T4 levels may fluctuate modestly as body composition changes on GLP-1 therapy
Not peer-reviewed in a major journal
This layered assessment explains why two women with similar-appearing scars may require very different treatments, and why addressing only one anatomical factor often produces incomplete correction